Novian Health

  • About Us
    • Overview
    • Management
    • Board Of Directors
    • Investors
  • Research & Products
    • Novilase® Breast Therapy
    • eIFU
    • Clinical Trials & Registries
    • Publications
    • Certificates
    • Intellectual Property
  • News
    • News & Press Releases
    • Media Coverage
    • Upcoming Events
  • Contact
    • Careers

NEWS & PRESS RELEASES

2022 2021 2020 2019 2015 2014 2013 2012 2011
2022
  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
2021
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)
2020
  • Novian Health Chosen As One of the Top 50 MedTech Startups Transforming the Healthcare Industry (23 September 2020)
  • Novian Health Adds Healthcare Leader Stephen Bonner to Board of Directors (09 September 2020)
  • MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator (22 June 2020)
2019
  • UK's Daily Mail Profiles One of the First Patients in Britain to Have Novilase Procedure (30 September 2019)
  • Novian Health Obtains CE Mark for Novilase Breast Therapy (16 July 2019)
  • Novian Health Chosen as Red Herring Top 100 North America Winner (05 June 2019)
2015
  • Breast Cancer Clinical Trial of Laser Ablation Treatment Shows Promising Results for Patients (10 Dec 2015)
2014
  • Novian Health President & CEO Interviewed by Med Device Insights
  • Walter Reed Bethesda Joins Novilase Clinical Trial (9 Sept 2014)
  • Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors (2 Sept 2014)
  • Novian Health Named Finalist for the 2014 Red Herring Top 100 North America Award (16 May 2014)
2013
  • Novian Health Awarded New Patent for Breast Cancer Treatment Technology (05 Dec 2013)
  • Novian Health Venture Capital Activity in 1Q 2013 for Breast Cancer Clinical Trials (18 April 2013)
  • Novian Health Closes $11 Million in Funding for Breast Cancer Clinical Trials (04 Feb 2013)
2012
  • Novian Health Begins Breast Cancer Clinical Trial (12 April 2012)
2011
  • Novian Health Founder Is Honored as Breast Cancer Leader by Chicago Komen Affiliate (20 Oct 2011)
  • Novian Health Awarded New Patent for Breast Tumor Treatment Technology (28 Sept 2011)
  • Novian Health Receives FDA Approval to Study Breast Cancer Therapy (14 July 2011)

ARCHIVES

MEDIA COVERAGE

NBC Denver 9NEWS Groundbreaking Breast Cancer Laser Treatment Novilase® (15 Dec 2015)

WABC 7 New York - Promising Research & Options in Breast Cancer
(10 Oct 2015)

NBC Denver 9NEWS Coverage on the Novilase® Clinical Trial at Rose Medical Center (10 Oct 2013)

WGN 9News Chicago – Novilase Breast Therapy for Benign Tumors (2007)

CBS Highlights New Laser Treatment being studied for Breast Cancer (2001)

UPCOMING EVENTS

 

 

CONTACT US

Novian Health Inc.
(Headquarters)
222 W Merchandise Mart Plaza
Suite 228
Chicago, Illinois 60654
Office: 312-266-7200
Fax: 312-266-7202
Email: info@novianhealth.com

    

LATEST NEWS

  • Novian Health Earns New Product Innovation Award for Novilase Breast Therapy (6 December 2022)
  • Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy (28 September 2021)
  • Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
  • Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
  • Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)

Copyright © 2026 Novian Health. All Rights Reserved. Privacy Policy.